167 related articles for article (PubMed ID: 2159542)
1. Identification of Epstein-Barr virus terminal protein 1 (TP1) in extracts of four lymphoid cell lines, expression in insect cells, and detection of antibodies in human sera.
Frech B; Zimber-Strobl U; Suentzenich KO; Pavlish O; Lenoir GM; Bornkamm GW; Mueller-Lantzsch N
J Virol; 1990 Jun; 64(6):2759-67. PubMed ID: 2159542
[TBL] [Abstract][Full Text] [Related]
2. Identification of the Epstein-Barr virus terminal protein gene products in latently infected lymphocytes.
Rowe DT; Hall L; Joab I; Laux G
J Virol; 1990 Jun; 64(6):2866-75. PubMed ID: 2159547
[TBL] [Abstract][Full Text] [Related]
3. Epstein-Barr virus nuclear antigen 2 activates transcription of the terminal protein gene.
Zimber-Strobl U; Suentzenich KO; Laux G; Eick D; Cordier M; Calender A; Billaud M; Lenoir GM; Bornkamm GW
J Virol; 1991 Jan; 65(1):415-23. PubMed ID: 1845900
[TBL] [Abstract][Full Text] [Related]
4. Immunological characterization of the Epstein-Barr virus phosphoprotein PP58 and deoxyribonuclease expressed in the baculovirus expression system.
Chen HF; Sauter M; Haiss P; Müller-Lantzsch N
Int J Cancer; 1991 Jul; 48(6):879-88. PubMed ID: 1650330
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the antibody response to the latent infection terminal proteins of Epstein-Barr virus in patients with nasopharyngeal carcinoma.
Frech B; Zimber-Strobl U; Yip TT; Lau WH; Mueller-Lantzsch N
J Gen Virol; 1993 May; 74 ( Pt 5)():811-8. PubMed ID: 8388017
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal and polyclonal antibodies against Epstein-Barr virus nuclear antigen 5 (EBNA-5) detect multiple protein species in Burkitt's lymphoma and lymphoblastoid cell lines.
Finke J; Rowe M; Kallin B; Ernberg I; Rosén A; Dillner J; Klein G
J Virol; 1987 Dec; 61(12):3870-8. PubMed ID: 2824821
[TBL] [Abstract][Full Text] [Related]
7. High-level expression of the Epstein-Barr virus alkaline deoxyribonuclease using a recombinant baculovirus: application to the diagnosis of nasopharyngeal carcinoma.
Baylis SA; Purifoy DJ; Littler E
Virology; 1991 Mar; 181(1):390-4. PubMed ID: 1847261
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
[TBL] [Abstract][Full Text] [Related]
9. Expression of Epstein-Barr virus nuclear antigen 2 in insect cells from a baculovirus vector.
Schubach WH; Horvath G; Spoth B; Hearing JC
Virology; 1991 Nov; 185(1):428-31. PubMed ID: 1656595
[TBL] [Abstract][Full Text] [Related]
10. Identification and characterization of an Epstein-Barr virus early antigen that is encoded by the NotI repeats.
Nuebling CM; Mueller-Lantzsch N
J Virol; 1989 Nov; 63(11):4609-15. PubMed ID: 2552144
[TBL] [Abstract][Full Text] [Related]
11. 5-Azacytidine up regulates the expression of Epstein-Barr virus nuclear antigen 2 (EBNA-2) through EBNA-6 and latent membrane protein in the Burkitt's lymphoma line rael.
Masucci MG; Contreras-Salazar B; Ragnar E; Falk K; Minarovits J; Ernberg I; Klein G
J Virol; 1989 Jul; 63(7):3135-41. PubMed ID: 2470924
[TBL] [Abstract][Full Text] [Related]
12. Cloning and characterization of cDNA clones corresponding to transcripts from the BamHI G region of the Epstein-Barr virus genome and expression of BGLF2.
Chen MR; Hsu TY; Lin SW; Chen JY; Yang CS
J Gen Virol; 1991 Dec; 72 ( Pt 12)():3047-55. PubMed ID: 1662696
[TBL] [Abstract][Full Text] [Related]
13. A second Epstein-Barr virus membrane protein (LMP2) is expressed in latent infection and colocalizes with LMP1.
Longnecker R; Kieff E
J Virol; 1990 May; 64(5):2319-26. PubMed ID: 2157888
[TBL] [Abstract][Full Text] [Related]
14. Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes.
Rowe M; Lear AL; Croom-Carter D; Davies AH; Rickinson AB
J Virol; 1992 Jan; 66(1):122-31. PubMed ID: 1309242
[TBL] [Abstract][Full Text] [Related]
15. Comparison of human sera reactivities in immunoblots with recombinant human herpesvirus (HHV)-8 proteins associated with the latent (ORF73) and lytic (ORFs 65, K8.1A, and K8.1B) replicative cycles and in immunofluorescence assays with HHV-8-infected BCBL-1 cells.
Zhu L; Wang R; Sweat A; Goldstein E; Horvat R; Chandran B
Virology; 1999 Apr; 256(2):381-92. PubMed ID: 10191203
[TBL] [Abstract][Full Text] [Related]
16. The BFRF1 gene of Epstein-Barr virus encodes a novel protein.
Farina A; Santarelli R; Gonnella R; Bei R; Muraro R; Cardinali G; Uccini S; Ragona G; Frati L; Faggioni A; Angeloni A
J Virol; 2000 Apr; 74(7):3235-44. PubMed ID: 10708440
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of Epstein Barr viral transcripts for two proteins (TP1 and LMP) in lymphocyte and epithelial cells.
Smith PR; Griffin BE
Nucleic Acids Res; 1991 May; 19(9):2435-40. PubMed ID: 1710355
[TBL] [Abstract][Full Text] [Related]
18. Different Epstein-Barr virus-B cell interactions in phenotypically distinct clones of a Burkitt's lymphoma cell line.
Gregory CD; Rowe M; Rickinson AB
J Gen Virol; 1990 Jul; 71 ( Pt 7)():1481-95. PubMed ID: 2165133
[TBL] [Abstract][Full Text] [Related]
19. Bluetongue virus tubules made in insect cells by recombinant baculoviruses: expression of the NS1 gene of bluetongue virus serotype 10.
Urakawa T; Roy P
J Virol; 1988 Nov; 62(11):3919-27. PubMed ID: 2845115
[TBL] [Abstract][Full Text] [Related]
20. Induction of anti-EBNA-1 protein by 12-O-tetradecanoylphorbol-13-acetate treatment of human lymphoblastoid cells.
Wen LT; Tanaka A; Nonoyama M
J Virol; 1989 Aug; 63(8):3315-22. PubMed ID: 2545906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
